Cited by 482Liver physiology and pathologyLiver Disease and TransplantationLiver Disease Diagnosis and Treatment

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Liver sinusoidal endothelial cells in hepatic fibrosis

Open access

DeLeve, Laurie D.·2015·Hepatology

Open this paper in CoChat — free account

Abstract

Capillarization, lack of liver sinusoidal endothelial cell (LSEC) fenestration, and formation of an organized basement membrane not only precedes fibrosis, but is also permissive for hepatic stellate cell activation and fibrosis. Thus, dysregulation of the LSEC phenotype is a critical step in the fibrotic process. Both a vascular endothelial growth factor (VEGF)‐stimulated, nitric oxide (NO)‐independent pathway and a VEGF‐stimulated NO‐dependent pathway are necessary to maintain the differentiated LSEC phenotype. The NO‐dependent pathway is impaired in capillarization and activation of this pathway downstream from NO restores LSEC differentiation in vivo . Restoration of LSEC differentiation in vivo promotes HSC quiescence, enhances regression of fibrosis, and prevents progression of cirrhosis. (H epatology 2015;61:1740–1746)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/hep.27376

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201840109 · Cited by 805 · cited 1×
“In vivo studies have suggested that activated HSCs do not revert to full quiescence upon regression of fibrosis, but that HSCs that develop a quiescent phenotype after regression of fibrosis are poised to rapidly reactivate when challenged with a fibrotic stimulus.(47) These HSCs have been termed inactivated HSCs.”
Background
Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance
Limmer, A., Ohl, J., Kurts, C., Ljunggren, H.-G., Reiss, Y., Groettrup, M., Momburg, F., Arnold, B., & Knolle, P. A. (2000) · Nature Medicine · doi:10.1038/82161 · Cited by 758 · cited 1×
“In normal liver, LSECs are tolerogenic (44, 45).”
Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice
Pradere, J.-P., Kluwe, J., De Minicis, S., Jiao, J.-J., Gwak, G.-Y., Dapito, D. H., Jang, M.-K., Guenther, N. D., Mederacke, I., Friedman, R., et al. (2013) · Hepatology · doi:10.1002/hep.26429 · Cited by 613 · cited 1×
“During chronic liver disease, Kupffer cells prevent HSC apoptosis and thereby sustain the fibrotic process.(51) Thus, there is an intricate interplay among the nonparenchymal cells that either prevents or sustains HSC activation and thereby determines fibrosis (Fig.”
Capillarization of hepatic sinusoids in man
Schaffner, F., & Popper, H. (1963) · Gastroenterology · doi:10.1016/s0016-5085(63)80130-4 · Cited by 610 · cited 1×
“INTRODUCTION Capillarization, which is when liver sinusoidal endothelial cells (LSECs) lack fenestration and develop an organized basement membrane (1), is a prelude to fibrosis.”
Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis
Corpechot, C., Barbu, V., Wendum, D., Kinnman, N., Rey, C., Poupon, R. Y., Housset, C., & Rosmorduc, O. (2002) · Hepatology · doi:10.1053/jhep.2002.32524 · Cited by 483 · cited 1×
“VEGF is upregulated in cirrhosis (33, 34), so that total VEGF is not rate limiting in this process.”
Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis.
Jarnagin, W. R., Rockey, D. C., Koteliansky, V., Wang, S. S., & Bissell, D. M. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.127.6.2037 · Cited by 452 · cited 2×
“LSECs in a bile duct ligation model make increased quantities of EIIIAfibronectin.(42) HSCs cultured on matrix conditioned by LSECs isolated from the bile duct ligation model show increased activation that is blocked by antibodies to EIIIA fibronectin.”
Background
LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis.
Carreira, C. M., Nasser, S. M., di Tomaso, E., Padera, T. P., Boucher, Y., Tomarev, S. I., & Jain, R. K. (2001) · PubMed · Cited by 444
Apoptotic Body Engulfment by a Human Stellate Cell Line Is Profibrogenic
Canbay, A., Taimr, P., Torok, N., Higuchi, H., Friedman, S., & Gores, G. J. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000069036.63405.5c · Cited by 417 · cited 1×
“During resolution of fibrosis, the decline in activated HSC is due to both reversion to quiescence and apoptosis (28, 50).”
Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats
Xie, G., Wang, X., Wang, L., Wang, L., Atkinson, R. D., Kanel, G. C., Gaarde, W. A., & DeLeve, L. D. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.017 · Cited by 410
Self-citation
Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence
DeLeve, L. D., Wang, X., & Guo, Y. (2008) · Hepatology · doi:10.1002/hep.22351 · Cited by 408 · cited 5×
“Hepatocytes are unable to maintain HSC quiescence unless the culture medium is supplemented with an NO-donor, but it remains to be determined whether NO contributes to the paracrine effect of LSECs on HSC quiescence or whether other paracrine factors are necessary.(36) Our group and others have reported that NO produc…”
BackgroundMethodInfluentialSelf-citation

Flagged first, then by citations

Show all 50 references

Sorted by citations

Items 301–400 of 480

Angiotensin-converting enzyme 2 improves liver fibrosis in mice by regulating autophagy of hepatic stellate cells
Wu, Y., Yin, A.-H., Sun, J., Xu, W.-H., & Zhang, C. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i33.4975 · Cited by 12
Endothelial cell SMAD6 balances Alk1 function to regulate adherens junctions and hepatic vascular development
Kulikauskas, M. R., Oatley, M., Yu, T., Liu, Z., Matsumura, L., Kidder, E., Ruter, D. L., & Bautch, V. L. (2023) · Development · doi:10.1242/dev.201811 · Cited by 12
Human Multi-Lineage Liver Organoid Model Reveals Impairment of CYP3A4 Expression upon Repeated Exposure to Graphene Oxide
Romaldini, A., Spanò, R., Veronesi, M., Grimaldi, B., Bandiera, T., & Sabella, S. (2024) · Cells · doi:10.3390/cells13181542 · Cited by 12
“…CD31 expression is commonly associated with LSECs de-differentiation (a phenomenon called capillarization), which determines the loss of the typical fenestrae and the formation of an organized basement membrane, occurring in vivo at the onset of liver fibrosis or in vitro cultures of LSECs [76–78].”
Background
Exploring the Role of Peroxisome Proliferator-Activated Receptors and Endothelial Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease
Traconis, A. P. M., Uribe, M., & Barbero-Becerra, V. J. (2024) · Cells · doi:10.3390/cells13242055 · Cited by 10
New insights into therapeutic strategies for targeting hepatic macrophages to alleviate liver fibrosis
Zhang, J., Xie, Z., Zhu, X., Xu, C., Lin, J., Zhao, M., & Cheng, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114864 · Cited by 11
Inhibiting Th1/2 cells influences hepatic capillarization by adjusting sinusoidal endothelial fenestrae through Rho-ROCK-myosin pathway
Zhong, Y., Xu, M., Hu, J., Huang, X., Lin, N., & Deng, M. (2021) · Aging · doi:10.18632/aging.202425 · Cited by 11
Nuclear VEGFR-2 Expression of Hepatocytes Is Involved in Hepatocyte Proliferation and Liver Regeneration During Chronic Liver Injury
Lee, A.-R., Baek, S.-M., Lee, S.-W., Kim, T., Han, J. E., Bae, S., Park, S., Kim, T., Jeong, K., Choi, S., et al. (2021) · In Vivo · doi:10.21873/invivo.12400 · Cited by 10
Liver sinusoidal endothelial cells show reduced scavenger function and downregulation of Fc gamma receptor IIb, yet maintain a preserved fenestration in the Glmpgt/gt mouse model of slowly progressing liver fibrosis
Antwi, M. B., Dumitriu, G., Simón-Santamaría, J., Romano, J. S., Li, R., Smedsrød, B. H., Vik, A., Eskild, W., & Sørensen, K. K. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293526 · Cited by 10
Asparaginyl endopeptidase may promote liver sinusoidal endothelial cell angiogenesis via PI3K/Akt pathway
Li, N., Liu, C., Ma, G., Tseng, Y., Pan, D., Chen, J., Li, F., Zeng, X., Luo, T., & Chen, S. (2018) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2018.5709/2018 · Cited by 10
The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice
Bae, C., Zhang, H., & Kwon, Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243497 · Cited by 10
Correction: The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice
Bae, C., Zhang, H., & Kwon, Y. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249747 · Cited by 10
ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells
Wang, L., He, L., Yi, W., Wang, M., Xu, F., Liu, H., Nie, J., Pan, Y.-H., Dang, S., & Zhang, W. (2024) · iScience · doi:10.1016/j.isci.2024.110273 · Cited by 11
Collagen-rich liver-derived extracellular matrix hydrogels augment survival and function of primary rat liver sinusoidal endothelial cells and hepatocytes
Wang, J., Zhao, F., Brouwer, L. A., Buist‐Homan, M., Wolters, J. C., Moshage, H. J., & Harmsen, M. C. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134717 · Cited by 9
Endothelial specialization and angiocrine factors are critical for vascularized organoid models
Fitzsimmons, R. L., & Hudson, J. E. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116410 · Cited by 10
P2X7 Receptor in Alcoholic Steatohepatitis and Alcoholic Liver Fibrosis
Xia, G., Fang, Q., Cai, J.-N., Li, Z.-X., Zhang, F.-Z., & Lv, X. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00022 · Cited by 9
Strategic approach in hepatic delivery of andrographolide: Key challenges and new insights
Mandal, D. D., Mandal, T., & Hazra, M. (2020) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2020.100411 · Cited by 9
The Immunomodulatory Properties of Mesenchymal Stem Cells Play a Critical Role in Inducing Immune Tolerance after Liver Transplantation
Li, S.-W., Cai, Y., Mao, X., He, S.-Q., Chen, Y., Yan, L., Zhou, J., Song, Y.-Q., Ye, L., & Zhou, X.-B. (2021) · Stem Cells International · doi:10.1155/2021/6930263 · Cited by 9
“In addition to NK cells, liver sinusoidal endothelial cells (LSECs) also exert a strong impact on the immune rejection and tolerance of liver allotransplantation [58].”
Background
Continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier
Tran, N. L., Ferreira, L. M., Alvarez-Moya, B., Buttiglione, V., Ferrini, B., Zordan, P., Monestiroli, A., Fagioli, C., Bezzecchi, E., Scotti, G. M., et al. (2022) · eLife · doi:10.7554/elife.80690 · Cited by 9
STED microscopy: A simplified method for liver sinusoidal endothelial fenestrae analysis
Martino, J. S. D., Mascalchi, P., Legros, P., Lacomme, S., Gontier, É., Bioulac‐Sage, P., Balabaud, C. P., Moreau, V., & Saltel, F. (2018) · Biology of the Cell · doi:10.1111/boc.201800016 · Cited by 9
“The exchanges are enhanced by the concomitant lack of basal membrane surrounding the capillaries [DeLeve, 2015].”
Background
Liver fibrosis regression correlates with downregulation in liver angiogenesis in chronic hepatitis C through viral eradication
Chen, S., Huang, C.-L., Chiang, I., Chang, T.-C., Wang, H., Hsu, W., Tsai, T.-Y., & Peng, C. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001833 · Cited by 9
Localized inhibition of platelets and platelet derived growth factor by a matrix targeted glycan mimetic significantly attenuates liver fibrosis
Kabra, H., Walimbe, T., Stuart, K., Indey, C., Jalgaonkar, S. P., Ikwa, E., Skurnac, T., Chen, J., Woolley, A. J., Snead, N. M., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120538 · Cited by 9
Matrix Stiffness Regulates Liver Sinusoidal Endothelial Cell Function Mimicking Responses in Fatty Liver DiseasePreprint
Natarajan, V., Moeller, M., Casey, C. A., Harris, E. N., & Kidambi, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.27.921353 · Cited by 9
“Studies report that capillarization event of the highly specialized LSEC phenotype is a vital gatekeeper event in the progression of metabolic liver diseases such as hepatitis (5) nonalcoholic fatty liver disease (6), alcoholic liver disease (7) (8) and liver fibrosis (9) (10).”
Background
Processing of angiocrine alarmin IL-1α in endothelial cells promotes lung and liver fibrosis
Zhang, C., Ma, J., Zhang, X., Zhou, D., Cao, Z., Qiao, L., Chen, G., Yang, L. M., & Ding, B. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112176 · Cited by 8
Changes in the proteome and secretome of rat liver sinusoidal endothelial cells during early primary culture and effects of dexamethasone
Li, R., Bhandari, S., Martínez-Zubiaurre, I., Bruun, J., Urbárová, I., Smedsrød, B. H., Simón-Santamaría, J., & Sørensen, K. K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273843 · Cited by 9
Nucleophagic Degradation of Progerin Ameliorates Defenestration in Liver Sinusoidal Endothelium Due to SIRT1-Mediated Deacetylation of Nuclear LC3
Bai, Y., Liu, J., Jiang, X., Li, X., Zhang, B., & Luo, X. (2022) · Cells · doi:10.3390/cells11233918 · Cited by 8
“The defenestration and capillarization of LSECs activate hepatic stellate cells (HSCs) and promote liver fibrosis, whereas maintaining LSEC fenestrae and reversing their capillarization can prevent the progression of liver fibrosis [1].”
Background
Autophagic degradation of MVBs in LSECs promotes Aldosterone induced-HSCs activation
Chen, T., Zhang, Y., Zhang, Y., Ning, Z., Xu, Q., Lin, Y. H., Gong, J., Li, J., Chen, Z., Meng, Y., et al. (2023) · Hepatology International · doi:10.1007/s12072-023-10559-0 · Cited by 8
“However, NO supplementation alone cannot inhibit the activation of HSCs [10], it appears to be some other mechanism along with NO-independent pathways, such as EVs, in the crosstalk between LSECs and HSCs. EVs are nano-sized membrane vesicles that are produced by virtually all cell types and carry…”
Logic-based modeling of inflammatory macrophage cross talk with glomerular endothelial cells in diabetic kidney disease
Patidar, K., & Versypt, A. N. F. (2025) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00362.2024 · Cited by 7
Role of cell autophagy in the generation of IgM and hepatic fibrosis in primary biliary cholangitis
Lian, C., Zhao, Y., Sun, J., Zhao, L., & Zhang, F. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05111-6 · Cited by 8
Plumbagin Alleviates Capillarization of Hepatic Sinusoids In Vitro by Downregulating ET-1, VEGF, LN, and Type IV Collagen
Li, G., Peng, Y., Tie-jian, Z., Lin, J., Duan, X.-L., Wei, Y., & Ma, J. (2017) · BioMed Research International · doi:10.1155/2017/5603216 · Cited by 8
“Nevertheless, the loss of fenestrae accompanied by a decrease in the diameter of the fenestrae is termed defenestration and results in the formation of a continuous basement membrane [9, 10].”
Background
Transcriptome Analyses of Liver Sinusoidal Endothelial Cells Reveal a Consistent List of Candidate Genes Associated with Endothelial Dysfunction and the Fibrosis Progression
Li, P., Xie, W., Wei, H., Yang, F., Chen, Y., & Li, Y. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46080473 · Cited by 7
“DAMPs and cytokines secreted by LSECs further activate hepatic stellate cells, leading to excessive production and deposition of extracellular matrix (ECM), thereby promoting the development of liver fibrosis [10].”
Background
G protein-coupled receptor GPR182 negatively regulates sprouting angiogenesis via modulating CXCL12-CXCR4 axis signaling
Chen, C., Liu, W., Yuan, F., Wang, X., Xu, X., Ling, C. C., Ge, X., Shen, X., Li, B., Shen, Y., et al. (2025) · Angiogenesis · doi:10.1007/s10456-025-09977-5 · Cited by 8
“Experiments involving human samples were approved by the Affiliated Hospital of Nantong University (2020-K013). termed LSEC capillarization [ 42].”
Exploring the double-edged role of cellular senescence in chronic liver disease for new treatment approaches
Yang, Y., Cai, Q., Zhu, M., Rong, J., Feng, X., & Wang, K. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123678 · Cited by 9
Purinergic Signaling in Non-Parenchymal Liver Cells
Martínez, E. M., Ramírez‐Ledesma, M. G., Vázquez‐Victorio, G., Hernández-Muñoz, R. E., Díaz‐Muñoz, M., & Vázquez‐Cuevas, F. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179447 · Cited by 7
“Liver sinusoidal endothelial cells (LSECs) are highly specialized vascular cells surrounding the hepatic lobule [160,161].”
Background
The role of the Notch signaling pathway in liver injury and repair
Yue, Z., Ruan, B., Duan, J., Han, H., & Wang, L. (2018) · Journal of Bio-X Research · doi:10.1097/jbr.0000000000000014 · Cited by 7
“4).([18,64,81]) Moreover, global ablation of Notch-1 led to nodular regenerative hyperplasia and dysregulated”
Background
Impact of omega-3 fatty acids on evolution of carbon tetrachloride- (CCl4) induced liver cirrhosis in mice : A histological and immunohistochemical study
Abu‐Dief, E. E., Mohammed, D., Haliem, N. G. A. E., Mohammed, S. A., & El‐Badry, A. M. (2018) · The Egyptian Journal of Histology · doi:10.21608/ejh.2018.7522 · Cited by 7
Angiogenesis and Hepatic Fibrosis: Western and Chinese Medicine Therapies on the Road
Wang, J., Zhang, Q., Cheng, J.-L., Chen, L.-Y., Nai-li, Y., Sun, G., & Chu, Y.-L. (2018) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-018-3007-1 · Cited by 7
Application of a layered model for determination of the elasticity of biological systems
Rusaczonek, M., Zapotoczny, B., Szymoński, M., & Konior, J. (2019) · Micron · doi:10.1016/j.micron.2019.102705 · Cited by 7
Liver Sinusoidal Endothelial Cells: An Antiviral “Defendothelium”
Klenerman, P., & Ramamurthy, N. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.12.010 · Cited by 7
“This has not only an immediate impact on virus control, but also longer term consequences for tissue repair and fibrosis.(1) Perhaps further studies to harness and control these mechanisms could provide new avenues for treatment of acute and chronic virus infections.”
Background
Transforming Growth Factor-β Signaling in Alcohol-Associated Liver Disease
Zou, H., Wang, S., Huang, C., Dooley, S., & Meindl‐Beinker, N. M. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.09.017 · Cited by 7
“31 Additionally, infiltrating immune cells, particularly T cells and monocyte-derived macrophages, produce cytokines, such as IL-17 and osteopontin, that reinforce TGF-β signaling in HSCs. 32 These multidirectional communications form a feed-forward loop, where parenchymal injury fuels…”
An Endothelial Cell Is Not Simply an Endothelial Cell
Limbu, S., & McCloskey, K. E. (2024) · Stem Cells and Development · doi:10.1089/scd.2024.0088 · Cited by 6
Impact of heterogeneity in liver matrix and intrahepatic cells on the progression of hepatic fibrosis
Sun, Z., & Chen, G. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102559 · Cited by 7
Impact of oxidized low-density lipoprotein on rat liver sinusoidal endothelial cell morphology and function
Mao, H., Kruse, L. D., Li, R., Oteiza, A., Struck, E. C., Schürstedt, J., Hübner, W., Cogger, V. C., Couteur, D. G. L., Wolfson, D. L., et al. (2024) · npj gut and liver. · doi:10.1038/s44355-024-00009-5 · Cited by 5
Liver sinusoidal endothelial cells in morphogenesis of pediatric autoimmune hepatitis. Ultrastructural characteristics – a novel report
Łotowska, J. M., Sobaniec-Lotowska, M. E., Sobaniec, P., & Lebensztejn, D. M. (2019) · Polish Journal of Pathology · doi:10.5114/pjp.2018.81691 · Cited by 6
Synthetic liver fibrotic niche extracts achieve in vitro hepatoblasts phenotype enhancement and expansion
Zhang, Y., Guo, A., Lyu, C., Bi, R., Wu, Z., Li, W., Zhao, P., Niu, Y., Na, J., Xi, J., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103303 · Cited by 6
“…treated by those pro-fibrotic factors became injured accompanied by an increase in cell body roundness while HSCs and LSECs were activated with a rise in length-to-width ratio to transform into myofibroblasts and undergo capillarization respectively (DeLeve, 2015; Tanaka and Miyajima, 2016).”
Background
Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease
Kotlyarov, S. N. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i4.597 · Cited by 6
Depletion of Activated Hepatic Stellate Cells and Capillarized Liver Sinusoidal Endothelial Cells Using a Rationally Designed Protein for Nonalcoholic Steatohepatitis and Alcoholic Hepatitis Treatment
Mishra, F., Yuan, Y., Yang, J. J., Li, B., Chan, P., & Liu, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137447 · Cited by 6
“…remodeling, and intrahepatic angiogenesis are tightly coupled. α HSCs strongly stimulate intrahepatic angiogenesis and sinusoidal remodeling. α HSCs secrete a number of molecular factors that promote LSEC growth migration and dedifferentiation [31,32], while caLSECs maintain HSC activation [33].”
Background
Scintigraphic liver function and transient elastography in the assessment of patients with resectable hepatocellular carcinoma
Rassam, F., Olthof, P. B., Takkenberg, R. B., Beuers, U. H., Klümpen, H., Bennink, R. J., van Lienden, K. P., Besselink, M. G., Busch, O. R., Verheij, J., et al. (2018) · HPB · doi:10.1016/j.hpb.2018.09.021 · Cited by 6
Isolation and Characterization of Mouse Primary Liver Sinusoidal Endothelial Cells
Guo, Q., Furuta, K., Aly, A., & Ibrahim, S. H. (2021) · Journal of Visualized Experiments · doi:10.3791/63062 · Cited by 8
Vessels With Cingulin Are Leakproof
Givens, C., & Tzima, E. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307238 · Cited by 6
“Endothelial cells (ECs) specialize their barrier function, as in brain ECs, where the blood–brain barrier protects neurons against toxins, or in liver ECs, where they are highly fenestrated for efficient filtering of the blood.(3) Angiogenesis also relies on regulation of EC junctions.”
Background
Inhibition of MALT1 Protease Attenuates Hepatic Sinusoidal Obstruction Syndrome by Modulating NRF2 / HO1 and NF‐κB Pathway
Sharma, N., Chandra, Y., & Andugulapati, S. B. (2025) · Liver International · doi:10.1111/liv.70050 · Cited by 5
Immune-endothelial cell crosstalk in hepatic endothelial injury of liver fibrotic mice
Fan, X., Tang, Q., Xia, N., Wang, J., Zhao, W., Jin, M., Lu, Q., Hu, J., Zhang, R., Zhang, L., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177730 · Cited by 5
Nanoparticle-based systems for liver therapy: Overcoming fibrosis and enhancing drug efficacy
Armillotta, M. G., Lizzi, L., & Massimi, M. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i10.108810 · Cited by 7
Activation of the Integrin αV-YAP-CTGF Axis in Liver Sinusoidal Endothelial Cells Promotes Liver Fibrogenesis, Leading to Portal Hypertension and Liver Carcinogenesis in Congestive Hepatopathy
Kato, S., Hikita, H., Tsukamoto, O., Sato, K., Kamizono, K., Sasaki, Y., Fukumoto, K., Myojin, Y., Murai, K., Tahata, Y., et al. (2026) · Gastroenterology · doi:10.1053/j.gastro.2025.11.014 · Cited by 5
Nanotherapy targeting liver sinusoidal endothelial cells in liver fibrosis
Zhang, L., Ru, J.-W., Liang, S.-Q., Zhang, M.-M., Zhang, C.-Y., Liu, J.-Q., Wang, Y., Zhou, T., Cheng, X. W., Xing, L., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114864 · Cited by 7
The vascular microenvironment and its stem cells regulate vascular homeostasis
Wang, Y., Zhang, X., Li, X., Cheng, M., & Cui, X. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1544129 · Cited by 8
“In the hepatic vascular microenvironment, liver sinusoidal endothelial cells (LSECs) exert paracrine regulatory effects on hepatocytes and hepatic stellate cells (HSCs) (DeLeve, 2015).”
Endotheliopathy of liver sinusoidal endothelial cells in liver disease
Kondo, R., Iwakiri, Y., Kage, M., & Yano, H. (2023) · Pathology International · doi:10.1111/pin.13361 · Cited by 5
“In addition, the LSECs maintain hepatic stellate cell quiescence, thus inhibiting intrahepatic vasoconstriction and fibrosis development.(4,6,7) In molecular pathology, LSECs express vascular endothelial growth factor receptor (VEGFR)−3, VEGFR‐2, VE‐ Cadherin, and Factor VIII, and are negative for CD34 and CD45 in nor…”
Nutritional and microbiota-based therapeutic interventions for alcohol-associated liver disease: From pathogenesis to therapeutic insights
Rangra, S., Rana, D., Prajapati, A., Benival, D. M., Dwivedi, P., & Mandoli, A. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122852 · Cited by 7
Antiviral Toll-like Receptor Signaling in Non-Parenchymal Liver Cells Is Restricted to TLR3
Werner, M., Schefczyk, S., Trippler, M., Treckmann, J. W., Baba, H. A., Gerken, G., Schlaak, J., & Broering, R. (2022) · Viruses · doi:10.3390/v14020218 · Cited by 5
Olmesartan Improves Hepatic Sinusoidal Remodeling in Mice with Carbon Tetrachloride‐Induced Liver Fibrosis
Wu, Y., Ge, X., Wang, S.-N., & Zhang, C. (2022) · BioMed Research International · doi:10.1155/2022/4710993 · Cited by 5
Endogenous Glycosaminoglycans in Various Pathologic Plasma Samples as Measured by a Fluorescent Quenching Method
Kantarcıoğlu, B., Mehrotra, S., Papineni, C., Siddiqui, F., Kouta, A., Hoppensteadt, D., Bansal, V., Darki, A., Thiel, D. H. V., & Fareed, J. (2022) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296221144047 · Cited by 5
“Additionally, loss of fenestrae and basement membrane deposition impedes the appropriate oxygenation of hepatocytes, resulting in apoptosis and necrosis and the secretion of damageassociated-molecular-patterns (DAMPs).(70) Following this, LSEC-derived factors, produce an excess of extracellular matrix and promote fibr…”
Background
Ultrasound‐Mediated Biomimetic Microbubbles Effectively Reverse LSECs Capillarization and Exert Antiplatelet Therapy in Liver Fibrosis
Deng, H., Ye, H., Xiao, H. P., You, Y., Miao, X., Zhang, W., Leng, Y., Zheng, R., Shuai, X., Ren, J., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500196 · Cited by 4
Obtusifolin mitigates CCl4-induced inflammation and liver fibrosis by modulating the ROCK2/ Cofilin-1 / NFκB pathway
Panneerselvam, S., Sharma, N., & Andugulapati, S. B. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178479 · Cited by 4
Activation of corticotropin releasing factor receptors up regulates collagen production by hepatic stellate cells via promoting p300 expression
Wang, C., Yang, S., Huang, J., Chen, S., Li, Y., & Li, Q. (2016) · Biological Chemistry · doi:10.1515/hsz-2015-0233 · Cited by 4
“The activated stellate cells secrete collagens to form scar tissue and play a critical role in the pathogenesis of cirrhosis (DeLeve, 2015).”
Background
Crosstalk Between Angiogenesis and Fibrogenesis in Liver Disease
Mejías, M., Balvey, A., & Fernández, M. (2020) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-020-00013-w · Cited by 6
Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
He, Z., Peng, C., Li, T., & Li, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.858905 · Cited by 4
“Capillarization can activate hepatic stellate cells (HSCs), resulting in liver fibrosis and progression of cirrhosis (DeLeve, 2015).”
Background
Uneven Distribution of Histologic Changes of “Blue Liver” Induced After Oxaliplatin-Based Chemotherapy for Colon Cancer
Fujii, A., Tateoka, T., Okuyama, T., Matsushima, J., Sato, T., Ono, Y., & Ban, S. (2019) · International Journal of Surgical Pathology · doi:10.1177/1066896919883407 · Cited by 4
Application Value of Magnetic Resonance Perfusion Imaging in the Early Diagnosis of Rat Hepatic Fibrosis
Fan, G., Ya, Y., Ni, X., Hou, J., & Yu, R. (2019) · BioMed Research International · doi:10.1155/2019/5095934 · Cited by 4
“A variety of pathogenic factors lead to changes in the morphology and function of the sinusoidal endothelial cells; for example, the fenestrae gradually shrink or even disappear, the subcutaneous basement membrane is formed, and continuous capillaries, known as sinusoid capillarization is observed [16, 17].”
Background
Single-cell transcriptomic profiling of healthy and fibrotic adult zebrafish liver reveals conserved cell identities and stellate cell activation phenotypes with human liverPreprint
Morrison, J. K., DeRossi, C., Alter, I. L., Nayar, S., Giri, M., Zhang, C., Cho, J. H., & Chu, J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.06.455422 · Cited by 4
“Endothelial cells have established roles in both activation and reversion of HSCs in fibrogenesis (54).”
Background
Ultrasound‐Responsive Dual‐Prodrug Nanoassembly for “Fenestrae‐Restoration Strategy” in Liver Fibrosis Therapy
Liu, S., Zhang, M., Qiu, Z., Liu, X., Dou, Y., Křížková, S., Li, Z., Heger, Z., & Li, N. (2026) · Advanced Materials · doi:10.1002/adma.202518832 · Cited by 3
Prediction of trajectories and outcomes in early-stage metabolic dysfunction-associated steatotic liver disease: a narrative review
Bromfield, B. B., CHIMENE-WEISS, J. I., Gheewalla, G., Feldman, T., Mitten, E. K., Portincasa, P., & Baffy, G. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.103921 · Cited by 3
THE REACTION OF IMMUNOCOMPETENT LIVER CELLS DURING CHEMICAL CASTRATION OF MALE RATS CAUSED BY THE INTRODUCTION OF TRIPTORELIN ACETATE
Rud, M. V., Shepitko, V. I., Stetsuk, Y. V., Akimov, O. Y., Vilkhova, O. V., & Skotarenko, T. A. (2021) · World of Medicine and Biology · doi:10.26724/2079-8334-2021-2-76-238-242 · Cited by 3
Features of fibrosis regression abound in “non-cirrhotic” patients with resected hepatocellular carcinoma
Orr, C. E., Wang, P. L., Chen, L., & Wang, T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267474 · Cited by 3
“Progression to cirrhosis is also accompanied by a physiologic change in liver sinusoidal endothelial cells (LSECs) termed capillarization in which the cells lose fenestration and aberrantly express endothelial markers [28,29].”
Background
[An update of understanding of the hepatic vascular system and new research strategies].
Lin, Y., Liu, Z., Dong, M., & Zhou, W. (2022) · PubMed Central · doi:10.12122/j.issn.1673-4254.2022.12.22 · Cited by 3
Spatial Computational Hepatic Molecular Biomarker Reveals LSEC Role in Midlobular Liver Zonation Fibrosis in DILI and NASH Liver Injury
Puri, M. (2024) · International Journal of Translational Medicine · doi:10.3390/ijtm4020012 · Cited by 5
“LSECs act as determinants of hepatic fibrosis, where the process of capillarization precedes fibrosis in which LSECs lack fenestration and develop an organized basement membrane [8].”
Liver fibrosis
Chen, W., Yang, A., Zhang, N., & You, H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95262-0.00014-0 · Cited by 3
A novel EndMT inhibitor, xanthotoxin, attenuates non-alcoholic fatty liver disease by acting as TGFβR2 antagonist
Zhao, X., Xia, F., Dong, Z., Huang, W., Kong, X., Cui, Z., Yan, M., Gao, H., Rong, R., Wang, M., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156823 · Cited by 3
Deciphering the Dynamic Complexities of the Liver Microenvironment — Toward a Better Understanding of Immune-Mediated liver Injury Caused by Immune Checkpoint Inhibitors (ILICI)
Wang, T., Yeh, M. M., Avigan, M., Pelosof, L. C., & Feldman, G. M. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00629-2 · Cited by 4
“(68, 69) 99 Page 3 of 14 The AAPS Journal (2021) 23:99”
Cellular and Molecular Mechanism of Liver Fibrosis: A Critical Insight
Parida, G. R., Pattnaik, G., & Behera, A. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.01066 · Cited by 3
Therapeutic Effects of Albumin-Fused BMP7 on 2 Experimental Models of Liver Fibrosis
Takano, M., Watanabe, H., Toda, S., Nishida, K., Imafuku, T., Minayoshi, Y., Nakano, T., Maeda, H., & Maruyama, T. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b23-00254 · Cited by 3
When ceramides meet immune senescence, a GIMAP5 connection
Gope, A., & Mauro, C. (2024) · Nature Immunology · doi:10.1038/s41590-023-01736-2 · Cited by 3
Hepatic fibrogenesis
Bansal, M. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-26710-9.00008-0 · Cited by 3
Portal Hypertension—Molecular Mechanisms
Vorobioff, J., & Groszmann, R. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00034-5 · Cited by 3
Hepatic Stellate Cells as Target for Reversal of Fibrosis/Cirrhosis
Lotersztajn, S., & Mallat, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00011-7 · Cited by 3
Nanoengineered Biomaterials for the treatment of liver diseases
Ortega‐Ribera, M., Yeste, J., Villa, R., & Gracia‐Sancho, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813355-2.00018-1 · Cited by 4
Loss of endothelial ZEB2 in mice attenuates steatosis early during metabolic dysfunction-associated steatotic liver disease
Dheedene, W., Verhulst, S., Demuynck, L., Callewaert, B., de Haan, W., Vinckier, S., Wauwe, J. V., Vandervoort, P., Lox, M., Stroobants, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-05881-6 · Cited by 2
Identification of a Novel Lipidomic Biomarker for Hepatocyte Carcinoma Diagnosis: Advanced Boosting Machine Learning Techniques Integrated with Explainable Artificial Intelligence
Yağın, F. H., Çolak, C., Al-Hashem, F. H., Alzakari, S. A., Alhussan, A. A., & Aghaei, M. (2025) · Metabolites · doi:10.3390/metabo15110716 · Cited by 2
“Despite challenges like data heterogeneity and model generalizability, ongoing developments in federated learning and multi-center validations are addressing these gaps [11,12,22].”
Bone morphogenetic protein (BMP)-9, a systemic homeostasis factor with diverse functions in the liver and beyond
Rana-Seyfert, D., Grab, A. L., & Breitkopf‐Heinlein, K. (2025) · Bioscience Reports · doi:10.1042/bsr20253294 · Cited by 2
“This process of capillarization represents a well-described promoter of pro-fibrogenic mechanisms in the liver, including HSC activation [55].”
Cellular senescence: from pathogenic mechanisms to precision anti-aging interventions
Deng, J., Sun, R., Bai, Z., Fang, L., Zhao, X., & Yang, D. (2026) · Aging · doi:10.18632/aging.206375 · Cited by 2
“Furthermore, it impedes the effective transport of insulin into the space of Disse, serving as a critical factor in inducing hepatogenic insulin resistance [34, 40, 41].”
Leading-Edge Approaches for In Vitro Hepatotoxicity Evaluation
LeCluyse, E. L., Norona, L. M., Akingbasote, J. A., Howell, L. S., Woodhead, J. L., Cross, M. J., Roth, A. B., & Goldring, C. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64267-8 · Cited by 2
Publication characteristics and visualized analysis of research about liver sinusoidal endothelial cells
Zhao, S., Zhang, L., Zhao, J., Tasnim, F., & Yu, H. (2023) · iLiver · doi:10.1016/j.iliver.2023.11.002 · Cited by 2
The effects of dark deprivation and chronic alcohol intoxication on the liver of rats
Areshidze, D. A., Kaktursky, L. V., Михалева, Л. М., & Kozlova, M. A. (2023) · Morphology · doi:10.17816/morph.623050 · Cited by 2
LiMAx test and ultrasound elastography to measure biomarkers of declining liver function in patients with liver fibrosis: A correlation analysis
Senk, K., Bártulos, C. R., Belkoura, J. M.-C., Schmid, S. A., Schlosser‐Hupf, S., Jung, E. M., Wiggermann, P., & Einspieler, I. (2024) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-248107 · Cited by 2
Development of novel nucleic acid therapy aimed at directly controlling liver fibrosis
Umezu, T., Takanashi, M., Fujita, K., Ishikawa, A., Harada, Y., Matsumoto, Y., Kuroda, M., & Murakami, Y. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102438 · Cited by 2
The Promising Role of Anti-Fibrotic Agent Halofuginone in Liver Fibrosis/Cirrhosis
Karakoyun, B. (2017) · InTech eBooks · doi:10.5772/intechopen.68641 · Cited by 2
“Upon liver injury, defenestration and capillarization of LSECs lead to impaired substrate exchange which is the major cause of hepatic dysfunction [57, 58] and HSC activation [61, 62].”
Background
Sinusoidal cell interactions—From soluble factors to exosomes
Ortega‐Ribera, M., Babuta, M., & Szabó, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95262-0.00002-4 · Cited by 1
The stem and progenitor cells and the functional activity of liver from age-different Wistar rats
Pershina, О. V., Uzyanbaev, I. A., Pakhomova, A. V., Pan, E. S., Kogai, L. V., Ermakova, N. N., Sandrikina, L. A., Kurbatov, B. K., & Krupin, V. A. (2024) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20240511 · Cited by 1
Comprehensive review of the vascular niche in regulating liver regeneration, fibrosis, and hepatocellular carcinoma
Chen, Y., Zhou, Y., Li, P., & Ding, B. (2025) · EngMedicine · doi:10.1016/j.engmed.2025.100070 · Cited by 1
Emerging vesicular nanosystems capable of effectively targeting hepatocytes
Chan, V., Pierre, A. S., Đỗ, T. H., & Li, S. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2534326 · Cited by 2
Gastrointestinal and Variceal Bleeding Under Atezolizumab–Bevacizumab in Hepatocellular Carcinoma: Evidence from Trials to Real-World Practice
Lee, H. B., & Kim, H. Y. (2026) · Cancers · doi:10.3390/cancers18091432 · Cited by 1
“At the molecular level, VEGF plays a central role in maintaining sinusoidal homeostasis through its regulation of endothelial nitric oxide synthase (eNOS) activity in liver sinusoidal endothelial cells (LSECs) [14].”
Antigen-specific tolerance and control of autoimmunity effected by liver sinusoidal endothelial cells is unimpaired in liver fibrosis
Gottwick, C., Averhoff, P., Casar, C., Liebig, L. A., Pilz, S. M., Haas, V., Krzikalla, D., Fleischer, S., Hübner, N., Adlung, L., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1834595 · Cited by 1

Authors: DeLeve, L. D.
Affiliations: University of Southern California (US)
Corresponding author: DeLeve, Laurie D.
ORCID: DeLeve, Laurie D.
Venue: Hepatology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2015-03-23
Volume: 61
Issue: 5
Pages: 1740-1746
ISSN: 0270-9139 (ISSN-L)
1527-3350
DOI: 10.1002/hep.27376
PMC: PMC4333127
OpenAlex: W1781806439
Cited by: 482
References: 50
Citations by year: 2026: 45 · 2025: 44 · 2024: 60 · 2023: 40 · 2022: 39 · 2021: 51 · 2020: 49 · 2019: 37 · 2018: 46 · 2017: 35 · 2016: 26 · 2015: 9
FWCI: 3.08
Type: journal article
Language: en
Update notices: correction (2015-07-01)
Open access: green
www.ncbi.nlm.nih.gov
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 162 d)
Locations: Hepatology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK100580, DK-66423, R01DK066423)
Topics: Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords: liver sinusoidal endothelial cells, liver fibrosis, capillarization, endothelial fenestrations, basement membrane formation, hepatic stellate cell activation, VEGF signaling, nitric oxide, HSC quiescence, fibrosis regression, liver cirrhosis
MeSH terms: Cell Differentiation, Humans, Liver Cirrhosis, Endothelial Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Liver sinusoidal endothelial cells in hepatic fibrosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks